Literature DB >> 27389276

Draft Genome Sequence for the Type Strain of Corynebacterium afermentans LCDC 88-0199T, Isolated from a Human Blood Culture.

Anne-Marie Bernier1, Kathryn Bernard2.   

Abstract

A draft genome for Corynebacterium afermentans LCDC 88-0199(T) was investigated. The size of the genome was 2,345,615 bp with an observed G+C content of 64.85%. Annotation revealed 2 rRNA sequences, 54 tRNA genes, and 2,164 coding sequences. Genome coverage was 85× and consisted of 24 contigs with an N50 of 187,988 bp.
Copyright © 2016 Bernier and Bernard.

Entities:  

Year:  2016        PMID: 27389276      PMCID: PMC4939793          DOI: 10.1128/genomeA.00661-16

Source DB:  PubMed          Journal:  Genome Announc


GENOME ANNOUNCEMENT

Corynebacterium afermentans sp. nov., first described for Gram-positive bacilli designated by the CDC as absolute nonfermenter 1 (CDC group ANF-1) (1), was divided into C. afermentans subsp. afermentans and C. afermentans subsp. lipophilum, with both subspecies being essentially nonreactive to most phenotypic substrates but differing by C. afermentans subsp. lipophilum being lipophilic (2). Blood culture isolate LCDC 88-0199T, identified as CDC group ANF-1 by Health Canada’s Laboratory Centre for Disease Control (LCDC) in Ottawa, Canada (now the National Microbiology Laboratory in Winnipeg, Canada), was shared with French colleagues in the early 1990s and subsequently selected as the C. afermentans subsp. afermentans type strain (2). Here, we describe the draft genome of Corynebacterium afermentans LCDC 88-0199T (= ATCC 51403T = CCUG 32103T = CIP 103499T = DSM 44280T = JCM 10390T). DNA from C. afermentans was purified using the TruSeq DNA HT sample preparation kit to prepare a paired-end whole-genome shotgun library, and sequencing was performed on the MiSeq Sequencer (Illumina 1.9, 2 × 300 cycles) according to manufacturer’s protocols, generating 1,265,540 reads and 379,796,318 detected bases, for an average estimated read coverage of 161×. Overlapping paired-end reads were merged using FLASH (3) to produce longer single reads that were subsequently assembled with paired-end reads using SPAdes genome assembler (St. Petersburg genome assembler, version 3.5.0) (4) using k-mer values of 21 to 127. This generated 71 contigs, which were subsequently filtered to remove repeated sequences and sequences <1 kb, leaving 24 contigs with an N50 of 1,870,988 bp. The average contig size was 97,733 bp with an average coverage of 85×. Gene prediction and annotation was performed with the NCBI Prokaryotic Genome Annotation Pipeline (http://www.ncbi.nlm.nih.gov/genome/annotation_prok), which revealed 5 rRNA genes, 52 tRNA genes, 51 pseudogenes, 2,197 genes, and 2,137 coding sequences. One clustered regularly interspaced short palindromic repeat sequence was found. The genome size of C. afermentans was 2,345,615 bp with a G+C content of 64.85%, which is comparable to the 66% G+C content obtained using high-performance liquid chromatography methods (2). Blast analysis using a locally constructed database from publically available sequences from C. glutamicum ATCC 13032T and C. diphtheriae NCTC 13129 revealed that the C. afermentans genome encoded for mycolate synthesis proteins, with identity ranging between 51% and 76% among proteins examined (data not shown) (5). Such data are consistent with the expected presence of mycolates. A fatty acid synthase (FAS) gene was also detected by in silico analysis, which is consistent with the nonlipophilic phenotype of C. afermentans. No phages were found in the genome using PHAST (http://phast.wishartlab.com) (6). LCDC 89-0199T, along with the other 8 C. afermentans isolates referred to here, has been described as being multidrug resistant (7). A homolog to the C. urealyticum ermX gene was found (93% protein identity), confirming the published resistance to clindamycin and erythromycin (7).

Nucleotide sequence accession number.

The draft whole-genome project for C. afermentans subsp. afermentans LCDC 89-0199T has been deposited at DDBJ/EMBL/GenBank under the accession number LXGG00000000.
  5 in total

1.  SPAdes: a new genome assembly algorithm and its applications to single-cell sequencing.

Authors:  Anton Bankevich; Sergey Nurk; Dmitry Antipov; Alexey A Gurevich; Mikhail Dvorkin; Alexander S Kulikov; Valery M Lesin; Sergey I Nikolenko; Son Pham; Andrey D Prjibelski; Alexey V Pyshkin; Alexander V Sirotkin; Nikolay Vyahhi; Glenn Tesler; Max A Alekseyev; Pavel A Pevzner
Journal:  J Comput Biol       Date:  2012-04-16       Impact factor: 1.479

2.  FLASH: fast length adjustment of short reads to improve genome assemblies.

Authors:  Tanja Magoč; Steven L Salzberg
Journal:  Bioinformatics       Date:  2011-09-07       Impact factor: 6.937

3.  Taxonomic study of Corynebacterium Group ANF-1 strains: Proposal of Corynebacterium afermentans sp. nov. containing the subspecies C. afermentans subsp. afermentans subsp. nov. and C. afermentans subsp. lipophilum subsp. nov.

Authors:  P Riegel; D de Briel; G Prévost; F Jehl; H Monteil; R Minck
Journal:  Int J Syst Bacteriol       Date:  1993-04

4.  Corynebacterium lowii sp. nov. and Corynebacterium oculi sp. nov., derived from human clinical disease and an emended description of Corynebacterium mastitidis.

Authors:  Kathryn A Bernard; Ana Luisa Pacheco; Courtney Loomer; Tamara Burdz; Deborah Wiebe; Chris Huynh; Brynn Kaplen; Adam B Olson; Margo Cnockaert; Hiroshi Eguchi; Tomomi Kuwahara; Haruyuki Nakayama-Imaohji; Hiroshi Shiota; Michael Boudewijns; Frederik Van Hoecke; Peter Vandamme
Journal:  Int J Syst Evol Microbiol       Date:  2016-04-05       Impact factor: 2.747

5.  PHAST: a fast phage search tool.

Authors:  You Zhou; Yongjie Liang; Karlene H Lynch; Jonathan J Dennis; David S Wishart
Journal:  Nucleic Acids Res       Date:  2011-06-14       Impact factor: 16.971

  5 in total
  1 in total

1.  Maturation of the oral microbiota during primary teeth eruption: a longitudinal, preliminary study.

Authors:  He Xu; Bijun Tian; Weihua Shi; Jing Tian; Wenjun Wang; Man Qin
Journal:  J Oral Microbiol       Date:  2022-03-16       Impact factor: 5.474

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.